Deaths from drug overdoses are the leading cause of injury death in the United States, ahead of deaths linked to motor vehicles and firearms, according to the new 2015 National Drug Threat Assessment (NDTA), released by the Drug Enforcement Administration.
Janet Woodcock, MD, director of the Center for Drug Evaluation and Research at the FDA, will speak about the future of drug development in pulmonary fibrosis during the PFF Summit 2015: From Bench to Bedside conference, November 12-14 in Washington D.C.
A survey of 2,398 physician leaders across the country indicates how physicians are changing their views on value-based care. View the survey findings.
After Valeant and Express Scripts cut ties with mail order specialty pharmacy Philidor Rx Services, the company said it would be closing.
Advancements in IV robotics are mitigating the risks of human error in the compounding process. The misconceptions of IV robotics are many, but there are also many real world examples of how hospitals and health systems are improving processes by implementing technology to support in-house sterile compounding.
Following the ICD-10 transition, real interplay between all stakeholders begins with the patient being the true focus.
While Gilead works on a “cure,” here are four things managed care executives need to know about the current state of HIV treatment
Today’s value-focused economy was a primary discussion point at a recent roundtable of health plan CEOs. The discussion led to five essential attributes that organizations must embrace to thrive.
FDA approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) and the stand-alone monotherapy Seebri Neohaler (glycopyrrolate) – which is one component of Utibron Neohaler -- for patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
As healthcare consumerism gains momentum, health plans need to change their offerings to keep up with consumer demands.
While many believe biosimilars have great potential, challenges remain.
These services can detect diseases earlier and prevent them altogether, but rates are lagging behind where they should be.
How advanced use of data and analytics can solve your biggest Star Ratings challenges
New research raises questions on supposed cost savings drive by mail order pharmacies.
Clinically Integrated Networks (CINs) are evolving quickly across the country in response to changing reimbursement trends and the move to value-based payments.
The FDA this week expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma - lowering the risk that melanoma will return following surgery.
A new report looks specifically at spending on healthcare for the privately insured in the U.S in 2014. Here are the findings.
The increasing use of behavioral health medications and polypharmacy in children is concerning, but a new Massachusetts program may help.
During their headline session at the AMCP conference, presenters from Avalere Health shared their predictions for "three futures" in the healthcare market.
The high cost of specialty medications requires an array of management techniques, according to a recent presentation at the Academy of Managed Care Pharmacy Nexus 2015. Read more.
For patients with diabetes or high blood cholesterol, greater medication adherence is associated with a greater likelihood that the patient will achieve target biometric A1c and low-density lipoprotein levels, respectively, according to a poster session presented at the Academy of Managed Care Pharmacy meeting.
A new online library or knowledge portal, the Type 2 Diabetes Genetics Beta, has been launched to provide open-access searching of genetic and clinical information on type 2 diabetes.
A pharmacist-led telemonitoring program reduced blood sugar levels in diabetics, according to a new study.
A senior clinical consultant at Express Scripts says it's critical for healthcare executives to keep an eye on recently approved specialty medications. Here are six to watch.
A new report from ACAP details savings afforded Medicaid programs through managed care
During their session at the AMPC conference in Orlando, presenters identified several diabetes management approaches that are improving medication adherence.
Study: Florida’s tougher drug laws and monitoring program is positively impacting opioid prevention efforts.
Make your messaging stand out
FDA has approved buprenorphine (Belbuca, Endo Pharmaceuticals) buccal film for use in patients with chronic pain.
FDA has approved idarucizumab (Praxbind, Boehringer Ingelheim) as the first reversal agent for Pradaxa.
